Pediatric Cancer Clinical Trials
32 studies are recruiting for pediatric cancer in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
By city
Studies now recruiting
-
Digital Art Therapy for Young Cancer Survivors
This is a single-site, single-arm, interventional study assessing the feasibility of the ARTCan Therapy Application (App) and whether it is an acceptable means of administering art therapy to young adult cancer survivors. The ARTCan Therapy App guides participants through a 6-week digital art thera…
- Stage
- Not phased
- Ages
- 18 to 25
- Site
- Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina
- Run by
- UNC Lineberger Comprehensive Cancer Center
-
Biomarkers of Resiliency In Childhood Cancer Surgery
This observational study is to better understand how children and their families recover after the stress of major surgery for cancer so that investigators can create ways to improve resilience during recovery. The main questions it aims to answer are: 1. Can information obtained from patients and …
- Stage
- Not phased
- Ages
- 3 to 25
- Site
- Mayo Clinic, Rochester, Minnesota
- Run by
- Mayo Clinic
-
Ovarian Tissue Cryopreservation in Post Pubertal (OTC-Post Pubertal)
The purpose of this study is to safely remove ovarian tissue in pediatric patients, who are at risk for infertility from their medical treatment, for freezing for future restoration of fertility and hormone function.
- Stage
- Not phased
- Ages
- Up to 30
- Site
- Ann &Robert H Lurie Children's Hospital, Chicago, Illinois
- Run by
- Erin Rowell
-
Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)
To evaluate the ability of a multidisciplinary and multisite group, the Pediatric Evolutionary Tumor Board (pedsETB), to develop additional therapeutic strategies in patients without curative options or with suboptimal outcomes.
- Stage
- Not phased
- Ages
- Any age
- Site
- Connecticut Children's Medical Center, Hartford, Connecticut
- Locations
- 3 in total
- Run by
- H. Lee Moffitt Cancer Center and Research Institute
-
Lurbinectedin in FET-Fused Tumors
The purpose of this study is to find out if a drug called lurbinectedin (the "study drug") is safe and effective at treating people with recurrent or relapsed solid tumors, including Ewing sarcoma.
- Stage
- Phase 1
- Ages
- 10 and older
- Site
- Cedars-Sinai Medical Center, Los Angeles, California
- Locations
- 6 in total
- Run by
- Children's Hospital of Philadelphia
-
Psychological Benefits of a Normalized Camping Experience for Children With Cancer
Background: * Cancer has an enormous impact on the psychological and social well-being of the family unit. The life-threatening connotations of cancer single out the ill child from his peer/family group as one who is different, and often unable to maintain a normal lifestyle. Physical sequelae of c…
- Stage
- Not phased
- Ages
- 7 to 25
- Site
- National Institutes of Health Clinical Center, Bethesda, Maryland
- Run by
- National Cancer Institute (NCI)
-
Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
This study will evaluate BCB-276, an investigational B7-H3-targeted Chimeric Antigen Receptor (CAR) T cell therapy, in children and young adults with diffuse intrinsic pontine glioma (DIPG). DIPG is a rare and aggressive brain tumor with limited treatment options. CAR T cell therapy uses a patient'…
- Stage
- Phase 2
- Ages
- 1 to 26
- Site
- Seattle Children's Hospital, Seattle, Washington
- Locations
- 6 in total
- Run by
- BrainChild Bio, Inc
-
Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
Papillary thyroid cancer (PTC) is the most common form of differentiated thyroid cancer (DTC). The traditional first line treatment for patients with advanced DTC after surgical resection is radioactive iodine (RAI) therapy. However, less than a quarter of patients with lung metastases will achieve…
- Stage
- Phase 2
- Ages
- 2 to 25
- Site
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
- Locations
- 5 in total
- Run by
- Children's Hospital of Philadelphia
-
Immune Function and Response to Vaccination After Cancer Therapy in Pediatric Patients
Pediatric cancer survivors have increased infection-related morbidity and mortality. This study will evaluate immune dysfunction following cancer directed systemic therapy completion, with attention to clinical relevance and infection rate in this population compared to healthy siblings, when appli…
- Stage
- Phase 2
- Ages
- 2 to 21
- Site
- Levine Cancer Institute, Charlotte, North Carolina
- Run by
- Wake Forest University Health Sciences
-
LCI-PED-NOS-EXER-001: Exercise in Pediatric Oncology Patients
The purpose of this study is to see if there are physical and emotional benefits to participating in a structured exercise regimen for those who are ages 2-25, are newly diagnosed with a blood or solid tumor cancer, and are currently undergoing or will begin cancer treatment.
- Stage
- Not phased
- Ages
- 2 to 25
- Site
- Levine Children's Hospital, Charlotte, North Carolina
- Run by
- Wake Forest University Health Sciences
-
Testing eSCCIP: An eHealth Psychosocial Intervention for English and Spanish Speaking Parents of Children With Cancer
It is critical to provide accessible evidence-based psychosocial support to parents and caregivers of children with cancer (PCCC) in order to mitigate individual and family-level psychosocial risks. This effectiveness trial evaluates an eHealth intervention for English- and Spanish-speaking (PCCC) …
- Stage
- Not phased
- Ages
- Any age
- Site
- Nemours Children's Health, Delaware, Wilmington, Delaware
- Locations
- 3 in total
- Run by
- Nemours Children's Clinic
-
Response to Influenza Vaccination in Pediatric Oncology Patients
Influenza infection occurring during oncologic treatment or following hematopoietic cell transplantation (HCT) is associated with increased risk of morbidity in the form of lower respiratory tract infection (LRTI) and mortality relative to otherwise healthy patients. The study participants have bee…
- Stage
- Not phased
- Ages
- Up to 18
- Site
- St. Jude Children's Research Hospital, Memphis, Tennessee
- Run by
- St. Jude Children's Research Hospital
-
LIFE Cancer Survivorship Database for Pediatric Cancer
The purpose of this study is to develop a mechanism for utilizing the comprehensive clinical database of childhood cancer survivors at Childrens Hospital Los Angeles (CHLA) for research purposes. Using clinical information obtained from follow-up visits of childhood cancer survivors, the database w…
- Stage
- Not phased
- Ages
- Any age
- Site
- Children's Hospital Los Angeles, Los Angeles, California
- Run by
- Children's Hospital Los Angeles
-
Post Mortem Tissue Donation of Pediatric Tumor Tissues and Cells
The objective of this study is to utilize all donated pediatric tumor tissues and cells obtained from autopsy to prospectively develop novel patient derived orthotopic xenograft (PDOX) mouse models as well as in vitro cell culture model systems for pediatric cancers, and also provide tissue samples…
- Stage
- Not phased
- Ages
- Any age
- Site
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois
- Run by
- Ann & Robert H Lurie Children's Hospital of Chicago
-
Multisite Implementation of COMPRENDO
COMPRENDO (ChildhOod Malignancy Peer Research NavigatiOn) is a multi-site randomized clinical trial (RCT) that uses a Hybrid Type 1 design, to test the effects of a clinical intervention on patient-level outcomes, while exploring multilevel implementation factors that can inform real-world setting …
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Children's of Alabama/University of Alabama at Birmingham, Birmingham, Alabama
- Locations
- 4 in total
- Run by
- University of California, San Diego
-
Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients
This is a phase I/II study to evaluate the safety of combining intravenous (IV) atezolizumab and bevacizumab every three weeks, with daily oral cyclophosphamide and pharmacokinetic (PK)-guided sorafenib in children and adolescent and young adults (AYA) with relapsed or refractory solid malignancies…
- Stage
- Phase 1
- Ages
- Up to 30
- Site
- St. Jude Children's Research Hospital, Memphis, Tennessee
- Locations
- 2 in total
- Run by
- St. Jude Children's Research Hospital
-
Video Inspired Discussions About Ethical Outcomes in Pediatrics
The goal of this clinical trial is to learn if the VIDEO-PEDS intervention works to improve Goals of Care communication between clinicians and parents of children with cancer. The main questions it aims to answer are: Does the intervention improve Goals of Care documentation? Does it improve patien…
- Stage
- Not phased
- Ages
- Any age
- Site
- Children's of Alabama at Birmingham, Birmingham, Alabama
- Locations
- 4 in total
- Run by
- Massachusetts General Hospital
-
UNC Childhood, Adolescent, and Young Adult Cancer Cohort
Purpose: This study aims to create a registry of childhood, adolescent, and young adult patients with cancer (<40 years-old at cancer diagnosis), entitled the 'UNC Childhood, Adolescent, and Young Adult Cancer Cohort' (UNC-CAYACC). This resource will serve to support cancer outcomes research among …
- Stage
- Not phased
- Ages
- 1 to 39
- Site
- University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
- Run by
- UNC Lineberger Comprehensive Cancer Center
-
Development and Evaluation of a Screening Approach for Sexual Dysfunction in AYA Patients With and Surviving Childhood Cancer
Prior research determined adolescent and young adult-aged childhood cancer survivor (AYA-CCS) and medical provider acceptability of the SexFS Brief in a controlled research setting. Development of an acceptable, effective, and feasible screening approach will result in improved recognition of SD in…
- Stage
- Not phased
- Ages
- 15 to 24
- Site
- Childrens Hospital Colorado, Aurora, Colorado
- Locations
- 2 in total
- Run by
- University of Colorado, Denver
-
Feasibility and Acceptability of Internet-based Parent-child Interaction Therapy (I-PCIT) in Pediatric Cancer
This study is being done to learn whether a telehealth intervention called "Internet-Based Parent Child Interaction Therapy," or I-PCIT," can help parents improve the child's behavior if the child currently or previously went through cancer treatment. Parents who choose to be in this study will com…
- Stage
- Not phased
- Ages
- Any age
- Site
- Johns Hopkins All Children's Hospital, St. Petersburg, Florida
- Run by
- Johns Hopkins All Children's Hospital
-
Massage Impact on Sleep in Pediatric Oncology
This study aims to determine the impact of massage therapy for pediatric patients receiving intensive chemotherapy or stem cell transplant (SCT).
- Stage
- Not phased
- Ages
- 12 to 21
- Site
- Children's Hospital of Philadelphia, Philadelphia, Pennsylvania
- Locations
- 2 in total
- Run by
- Children's Hospital of Philadelphia
-
Efficacy of Laser Interstitial Thermal Therapy in Young Persons With Low-grade Glioma
This study aims to evaluate the efficacy of Laser Interstitial Thermal Therapy (LITT) in treating recurrent or progressive, low-grade gliomas (LGG) in pediatric, adolescent and young adult patients.
- Stage
- Not phased
- Ages
- 2 to 25
- Site
- University of California, San Francisco, San Francisco, California
- Run by
- University of California, San Francisco
-
Shareholder-driven Co-design and Piloting of Spanish Educational Videos About High Yield Pediatric Oncology Topics
Families of children with cancer who speak languages other than English experience inequalities in healthcare, but little research has been done on solutions to improve care for these families. This study will partner parents with medical interpreters and clinicians to create educational videos abo…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Children's Hospital Colorado, Aurora, Colorado
- Run by
- University of Colorado, Denver
-
PediRISE Feasibility
The goal of this research study is to learn whether investigators can successfully give the PediRISE program to families-in other words, whether most families are interested in participating in a study about the PediRISE program, including a 50-50 chance of receiving standard usual care, and a 50-5…
- Stage
- Not phased
- Ages
- Up to 17
- Site
- University of California San Francisco, San Francisco, California
- Locations
- 4 in total
- Run by
- Dana-Farber Cancer Institute
-
Cancer Care Companion
This study invites parents of children with cancer to use an electronic health record (EHR)-based communication tool, called the Cancer Care Companion, and assess the acceptability, appropriateness, and feasibility of the tool.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Washington University School of Medicine/Saint Louis Children's Hospital, St Louis, Missouri
- Run by
- Washington University School of Medicine
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.